Collegium Pharmaceutical, Inc. COLL Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s total current liabilities?
- Collegium Pharmaceutical, Inc. (COLL) reported total current liabilities of $434.97M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s total current liabilities changed year-over-year?
- Collegium Pharmaceutical, Inc.'s total current liabilities decreased by 10.6% year-over-year, from $486.71M to $434.97M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s total current liabilities has grown at a 12.9% compound annual growth rate (CAGR), from $239.45M to $440.03M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.